about
Targeted drug delivery for cancer therapy: the other side of antibodies.Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Radioimmunotherapy in mantle cell lymphoma.
@en
type
label
Radioimmunotherapy in mantle cell lymphoma.
@en
prefLabel
Radioimmunotherapy in mantle cell lymphoma.
@en
P2860
P1476
Radioimmunotherapy in mantle cell lymphoma
@en
P2093
Alan P Skarbnik
P2860
P304
P356
10.1016/J.BEHA.2012.04.004
P577
2012-05-09T00:00:00Z